Laboratory services

Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 3 312
A002 Cell Blood Count 27 1 903
A005 Sedimentation rate 16 1 128
A008 Reticulocytes 13 916
A009 Matching of blood and compatibility test 290 20 438
M125 Malaria test 67 4 722
URINE ANALYSIS
B500 Standard urine test 13 916
B502 Standard urine test with microscopy 24 1 691
B510 Urine pregnancy test (screening) 13 916
B511 Nechiporenko urine test 20 1 410
B512 Zimnitsky urine test 53 3 735
B513 3-portions urine test examination 40 2 819
B514 2-portions urine test examination 27 1 903
B515 Urine precipitate - Microscopy 13 916
B517 Creatinine Clearance 53 3 735
STOOL ANALYSIS
B306 Fecal examination for pancreatic elastase-1 52 3 665
M105 Coprology total 27 1 903
M110 Coprology (occult blood) 13 916
M111 Carbohydrates in faeces 40 2 819
M115 Enterobiasis 20 1 410
M120 Eggs of helminths (+protozoa) 27 1 903
M122 Protozoa in faeces 20 1 410
M390 Adenovirus and rotavirus (in stool) 28 1 973
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 2 890
M391 Helicobacter pylori(in stool) 27 1 903
M393 Verotoxin in stool 50 3 524
M394 Norovirus in stool 25 1 762
M395 Calprotectin in stool (quantitative) 50 3 524
M396 Clostridium Difficile Toxin A & B 65 4 581
SPUTUM ANALYSIS
M150 Standard sputum test 27 1 903
M002 Nasal slime general clinical research 27 1 903
M355 M. Tuberculosis in sputum 33 2 326
SKIN& NAIL PLATES
M126 Microscopic examination of a scraping from the skin, papules and ulcers on the edges parasitos 18 1 269
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 3 312
M210 Demodex folliculorum 20 1 410
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 571
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 410
M221 Standard Cervical Smear Test 20 1 410
M222 Standard Urethral Smear Test 20 1 410
M223 Standard prostatic fluid test 27 1 903
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 1 903
B621 Standard Serous Fluid test 27 1 903
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 2 326
B623 Glucose in cerebrospinal fluid 17 1 198
B624 Protein in cerebrospinal fluid 17 1 198
HEMOSTASIS SYSTEM
A020 APTT 16 1 128
A025 Prothrombin+INR 27 1 903
A027 Thrombin time 22 1 550
A030 Fibrinogen 16 1 128
A035 Antithrombin III 27 1 903
C139 Protein-C 47 3 312
C142 Protein-S 47 3 312
C515 D-DIMER 60 4 229
C305 Lupus anticoagulant (panel) 53 3 735
A033 Platelet Aggregation 83 5 849
A031 FACTOR VON 170 11 981
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 114
BLOOD DRUG RATES
B142 Folic acid 27 1 903
C710 Determination of ethanol in the blood 60 4 229
T010 Digoxin 78 5 497
T015 Determination of phenobarbital in blood 53 3 735
T020 Phenytoin 53 3 735
T025 Valproic Acid 53 3 735
T030 Carbamazepine 53 3 735
T080 Determination of tacrolimus in blood 55 3 876
T085 Levetiracetam (Keppra) 100 7 048
T097 Therapeutic drug monitoring of Topiramate 23 1 621
T098 Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 23 1 621
T100 Determination of the concentration of Amikacin in the blood 40 2 819
T101 The determination of the concentration of Gentamicin in the blood 40 2 819
T102 Determine the concentration of Vancomycin in the blood 40 2 819
NARCOTIC SCREENING
T075 Drug screening in urine 53 3 735
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 2 749
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 13 179
T088 Amphetamines in urine (quantitative) 28 1 973
T089 Cocaine in urine (quantitative) 28 1 973
T090 Cannabinoids in urine (quantitative) 28 1 973
T091 Barbiturates in urine (quantitative) 25 1 762
T092 Benzodiazepines in urine (quantitative) 28 1 973
T095 Opiates in urine (quantitative) 28 1 973
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 53 3 735
T099 Determination of nicotine and its metabolites in urine for differential diagnosis of active and passive smoking: nicotine, cotinine (GH-MS method) 29 2 044
BLOOD BIOCHEMISTRY
A060 Vitamin B12 27 1 903
B002 Iron saturation of transferrin + Transferrin + Iron 39 2 749
B003 Ceruloplasmin 50 3 524
B004 Eosinophil Cationic Protein (ECP) 50 3 524
B007 Cuprum 22 1 550
B100 Glucose 13 916
B101 Standard glucose tolerance test 33 2 326
B102 Vitamin D 107 7 541
B103 Vitamin A 83 5 849
B104 Vitamin B1 83 5 849
B105 Cholesterol 13 916
B107 Pregnancy glucose tolerance test 33 2 326
B108 Vitamin B5 83 5 849
B109 Vitamin B6 83 5 849
B110 Cholesterol-HDL 20 1 410
B112 Vitamin C 83 5 849
B113 Vitamin E 83 5 849
B114 Vitamin K 83 5 849
B115 Cholesterol-LDL 20 1 410
B118 Lactate 25 1 762
B120 Triglycerides 13 916
B122 Angiotensin converting enzyme (ACE) 48 3 383
B125 Bilirubin total 13 916
B130 Bilirubin direct 13 916
B135 Albumin 13 916
B137 Homocysteine 67 4 722
B140 Creatinine 13 916
B144 Zink 38 2 678
B145 Iron 16 1 128
B148 Litium 74 5 215
B150 Iron binding capacity 20 1 410
B155 Total protein 13 916
B160 Protein fractionation (Electrophoresis) 27 1 903
B165 Lipoprotein A 27 1 903
B166 APO-A-1 protein 27 1 903
B167 APO-B protein 27 1 903
B170 Urea 13 916
B175 Uric acid 13 916
B180 Fructosamine 20 1 410
B188 Determination of bile acids in blood 45 3 171
B200 Calcium (total) 16 1 128
B202 Calcium (ionised) 20 1 410
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 10 571
B205 Sodium/Potassium/Chloride 16 1 128
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 1 903
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 1 903
B210 Magnesium 13 916
B215 Phosphate inorganic 13 916
B217 Complex blood analysis during dialysis: pH, glucose, electrolytes 136 9 585
B218 Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 47 3 312
B219 Study of dialysate for electrolyte composition, pH, glucose 131 9 232
B221 Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 47 3 312
B300 Amylase 16 1 128
B305 Amylase pancreatic 16 1 128
B310 Lipase 16 1 128
B315 Lactatedehydrogenase (LDH) 13 916
B317 Erythropoietin 47 3 312
B320 Creatine Kinase 13 916
B325 Creatine Kinase MB 16 1 128
B330 Gamma Glutamyle Transferase (GGT) 13 916
B335 Acid phosphatase 16 1 128
B340 Alk. Phosphatase 13 916
B345 Alanine Amino Transferase (ALT) 13 916
B350 Aspartate Amino Transferase (AST) 13 916
B360 Cholinesterase 18 1 269
B362 Determination of C1 esterase inhibitor in blood 45 3 171
B400 C-Reactive Protein 20 1 410
B401 C-reactive protein high sensitivity 30 2 114
B405 Rheumatoid Factor 20 1 410
B410 Anti-streptolysin O titre 20 1 410
B411 Alfa-1-antitrypsin 27 1 903
C415 Ferritin 27 1 903
B430 Haemoglobin A1C 22 1 550
B435 Myoglobin 47 3 312
B440 Transferrin 27 1 903
B445 Troponin I 47 3 312
B450 Troponin T 47 3 312
B451 BNP (brain natriuretic peptide) 87 6 131
B556 The N-terminal peptide NT-proBNP 88 6 202
B604 Alpha-2-Macroglobuline 47 3 312
B610 Haptoglobin 47 3 312
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 9 162
B702 Procalcitonin (quant) 60 4 229
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 3 312
B025 Microproteinuria 13 916
B132 Urea (random portion) 12 846
B133 Uric acid (random portion) 12 846
B139 The content of Cu (copper) in the urine (a single portion of urine) 13 916
B173 Glucose (random portion) 13 916
B182 Alpha Amylase (random portion) 18 1 269
B505 NA+/K+/Cl (random portion) 20 1 410
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 10 571
B134 Calcium (random portion) 18 1 269
B008 The content of Cu (copper) in the urine (daily) 13 916
B703 Gas chromatography of urine (organic aciduria) 250 17 619
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 269
B141 Creatinine (24h) 18 1 269
B171 Urea (24h) 18 1 269
B176 Uric acid (24h) 18 1 269
B177 Phosphate inorganic (24h) 18 1 269
B178 Magnesium (24) 18 1 269
B179 Glucose (24h) 18 1 269
B183 Total Protein (24h) 18 1 269
B506 Na (24h) 20 1 410
B507 K (24h) 20 1 410
B508 Cl (24h) 20 1 410
B516 Calcium urine test (24h) 22 1 550
B550 Oxalate in urine 40 2 819
B558 Determination of Beta-2-microglobulin (single dose of urine) 24 1 691
B562 Urine protein electrophoresis 40 2 819
B520 Stone chemistry - Profile 78 5 497
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 339
B420 Immunoglobulin M (IgM) 19 1 339
B425 Immunoglobulin G (IgG) 19 1 339
C299 Circulating Immune Complex 22 1 550
C300 IgE total 27 1 903
C285 Interferon sensibility state 293 20 649
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 14 095
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 14 095
C293 Compliment Componenta C3 33 2 326
C294 Compliment Componenta C4 33 2 326
C295 Neutrophilic Bactericidal Activity (HCT test) 27 1 903
C290 Interleukin 6 34 2 396
C291 Interleukin 8 34 2 396
C296 Interleukin 10 34 2 396
C298 Tumor Necrosis Factor 39 2 749
C281 Interleukin 1 Beta 50 3 524
C307 Determination of amyloid - beta (1-42) in blood and in cerebrospinal fluid 78 5 497
B704 Oligoclonal IgG in liquorrhea & serum 120 8 457
Diagnosis Of Auto-Immune Diseases
C023 Cardiolipin antibodies, IgM 50 3 524
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 5 849
C101 Anti-smooth muscle antibodies (ASMA) 50 3 524
C102 Anti-mitochondrial antibodies (AMA) 50 3 524
C167 Determination of аntibodies to nuclear antigens (ANA), IgG, 25 antigens: nucleosomes, dsDNA, histones, Sm, RNP(68kD/A/C), Sm / RNP, SSA / Ro 60kD, SSA / Ro 52kD, SSB, Scl-70, Ku, PM-Scl 100, Mi-2, Jo-1, PL-7, PL-12, SRP, ribosomes, CENP-a / B, GP100, PC100, M2, M2/nPDC and f-actin; quality, with decoding 115 8 105
C168 Determination of аntibodies to liver antigens, IgG, 7 antigens: M2 / nPDC, gp210, sp100, LKM1, LC1, SLA, f-actin; with decoding 45 3 171
C169 Determination of аntibodies for diagnosis of polymyositis/ scleroderma, IgG, 8 antigens: Jo - 1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl-100, Scl-70; quality,  with decoding 75 5 286
C171 Determination of аntibodies to extractable nuclear antigens (ENA screen) and nucleosomes, IgG, 7 antigens: nucleosomes, Sm, Sm/RNP, SSA (Ro), SSB (La), Jo-1, Scl-70; quality,  with decoding 21 1 480
C175 Determination of antibodies to myeloperoxidase (MPO), IgG; quantitative determination 17 1 198
C176 Determination of antibodies to proteinase 3 (PR3), IgG; highly sensitive method; quantitative determination 17 1 198
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 3 171
C203 Scl-70 antibodies 50 3 524
C225 Thyroglobulin antibody 33 2 326
C230 Thyroperoxidase antibody 33 2 326
C231 Auto AB TSH-receptor 53 3 735
C233 Antispermatic Antibodies 67 4 722
C235 AB Insulin IgG 40 2 819
C236 AB insular beta-cells 67 4 722
C240 Antibodies acetylcholine receptor 160 11 276
C241 Antibodies aquaporin 4( NMO) 80 5 638
C242 Antibodies skeletal muscles 70 4 933
C243 Antibodies gangliosides, blot 90 6 343
C244 Myositis antibodies, blot 90 6 343
C245 Anti-neuronal antibodies, blot 110 7 752
C246 Antibodies NMDA receptor 150 10 571
C247 Antibodies Sm 50 3 524
C248 Antibodies gliadine deamidated peptides IgG 45 3 171
C249 Antibodies gliadine deamidated peptides IgA 45 3 171
C250 Antibodies RNP-70 45 3 171
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 292 20 579
C253 Blood test on APG 105 7 400
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 51 3 594
C256 Definition of CD20 in peripheral blood 54 3 806
C257 Typing of CD-34 + cells 56 3 947
C258 Myelogram 122 8 598
C259 Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 83 5 849
C260 Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 83 5 849
C261 Determination of Tau protein in biological fluids 78 5 497
C262 Determination of glial fibrillar acid protein (GFAP) 106 7 470
C263 Comprehensive study (immunophenotyping) panel for serous discharge: CD45/CD15/CD71/CD40/CD95/CD30/CD3/CD19 300 21 143
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 35 2 467
C500 Nuclear antibody (IF) 47 3 312
C505 Cardiolipin antibody IgG 47 3 312
C506 Cardiolipin antibody IgA 25 1 762
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 288 20 297
C533 Anti-dsDNA 53 3 735
C534 Anti-ssDNA 53 3 735
C535 Phospholipid Antibody IgG 53 3 735
C536 Phospholipid Antibody IgM 53 3 735
C830 Antibodies Prothrombin 40 2 819
C840 Antibodies Gliadin IgA 40 2 819
C841 Anti-Transglutaminase IgG 47 3 312
C842 Anti-Transglutaminase IgA 47 3 312
C845 Antibodies Reticulin 47 3 312
C846 Antibodies Endomysium 47 3 312
C847 Antibodies Platelet 53 3 735
C848 Antibodies Basic Skin Membrane 73 5 145
C849 Determination of antibodies to the basement membrane of the glomeruli of the kidneys, IgG 35 2 467
C850 Antibodies Gliadin IgG 40 2 819
C851 Beta2 – glycoprotein antibodies 50 3 524
C852 Annexin V antibodies 50 3 524
C853 ENA – extractive nuclear antibodies screen 61 4 299
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 3 524
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 3 524
Immune Hematological Analysis
A066 Complex "Myeloma-test" 220 15 505
A069 Determination of free light chains FLC in blood 55 3 876
A070 Determination of free light chains (FLC) in urine 35 2 467
ONCOLOGICAL TESTS
C405 PSA total 29 2 044
C410 PSA free 29 2 044
C420 AFP 29 2 044
C425 CEA 29 2 044
C430 CA 125 38 2 678
C435 CA 19-9 29 2 044
C440 CA 15-3 29 2 044
C442 CA 72 - 4 40 2 819
C443 Neuron-Specific Enolase (NSE) 60 4 229
C445 B2 microglobulin 33 2 326
C820 Cyfra-21-1 40 2 819
C822 Squamous Cell Carcinoma (SCC) 39 2 749
C821 UBC (Bladder Cancer Antigen) in urine 39 2 749
C823 HE4 40 2 819
C824 Chromogranin A 55 3 876
SEROLOGY
Syphilis Diagnosis
S000 Determination of anti-cardiolipin antibodies by microreaction precipitation (RPR) (Diagnosis of syphilis) 27 1 903
S001 Determination of antibodies to Treponema pallidum (total) 27 1 903
S002 Determination of total antibodies to Treponema pallidum (quantitative) 30 2 114
S010 Determination of antibodies to Treponema pallidum by indirect hemagglutination(TPHA) 33 2 326
S011 Detection of antibodies to Treponema pallidum by the RIBT method 35 2 467
S012 Detection of antibodies to Treponema pallidum by the RIF method 20 1 410
S091 Determination of anti-Treponema pallidum IgG immunoblot 103 7 259
S092 Determination of anti-Treponema pallidum IgM immunoblot 103 7 259
Isoserological Study
A050 ABo Blood group+rhesus factor 33 2 326
A055 Antierythrocytic antibodies (screening) 40 2 819
A056 Direct Cumbs test 33 2 326
A061 Detecting Kell antigen sistem 33 2 326
A064 Phenotyping Rh and Kell 35 2 467
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1/2 + antigen p24 47 3 312
C001-SC Anti-HIV 1/2 + antigen p24 state certificate 79 5 568
C004 Anti-HAV total 40 2 819
C006 Anti-HAV IgM 47 3 312
C007 Hepatitis D Virus HDV antibodies, total 28 1 973
C008 HBsAg 27 1 903
C010 HBeAg 47 3 312
C011 HDV antibodies, IgM 28 1 973
C012 Anti-HBc total 40 2 819
C013 HEV antibodies, IgG 28 1 973
C014 Anti-HBc IgM 47 3 312
C015 HEV antibodies, IgM 28 1 973
C016 Anti-Hbe 47 3 312
C018 Anti-HBs quant. 47 3 312
C020 Anti-HCV IgG 40 2 819
C021 Anti-HCV IgM 44 3 101
C026 Anti-CMV IgG 29 2 044
C028 Anti-CMV IgM 33 2 326
C030 Anti-Rubella IgG 29 2 044
C031 Anti-Parvovirus B19 IgG 40 2 819
C032 Anti Rubella IgM 33 2 326
C033 Anti-Parvovirus B19 IgM 40 2 819
C034 Anti Mumps IgG 53 3 735
C036 Anti Mumps IgM 53 3 735
C038 Anti Measles IgG 53 3 735
C040 Anti Measles IgM 53 3 735
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 3 312
C044 Anti-HSV 1 IgG 47 3 312
C046 Anti-HSV 1 IgM 53 3 735
C048 Anti-HSV 2 IgG 47 3 312
C050 Anti-HSV 2 IgM 53 3 735
C052 Anti-Varicella Zoster IgG 53 3 735
C054 Anti Varicella Zoster IgM 53 3 735
C058 Anti-EBV-VCA IgG 53 3 735
C060 Anti-EBV-VCA IgM 53 3 735
C094 IgG Respiratory syncytial virus 35 2 467
C096 IgM Respiratory syncytial virus 35 2 467
C152 IgG Dengue virus 25 1 762
C153 IgM Dengue virus 25 1 762
C154 Antibodies to Clostridium tetani (quantitative) 35 2 467
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 3 876
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 3 876
C450 Adenovirus infection 67 4 722
C856 Anti- encephalitis IgG 55 3 876
C857 Anti- encephalitis IgM 55 3 876
S200 Cytomegalovirus (CMV) IgG Avidity 53 3 735
S210 Rubella IgG Avidity 38 2 678
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 3 312
C064 Helicobacter pylori antibody blot 80 5 638
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 3 312
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 4 722
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 4 722
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 4 722
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 9 162
C090 Borrelia burgdorf. IgG (qual) 67 4 722
C091 Borrelia burgdorf. IgM (qual) 67 4 722
C164 Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 25 1 762
C165 Serological diagnosis of borreliosis (immunochip) in blood 13 916
C177 Determination of urease activity Helicobacter pylori, 13C (urease respiratory test) 35 2 467
C519 Anti IgG Legionella pneumophila (qual.) 89 6 272
C522 Anti IgM Legionella pneumophila (qual.) 89 6 272
C645 Brucella IgG 67 4 722
C647 Brucella IgM 67 4 722
D070 Chlamydia pneumoniae IgA 53 3 735
D071 Chlamydia pneumoniae IgG 53 3 735
D072 Anti IgM Chlamydia pneumoniae 53 3 735
D073 Chlamydia psittaci IgG (qual) 67 4 722
D074 Chlamydia psittaci IgM (qual) 67 4 722
D077 Chlamydia psittaci IgA (qual) 67 4 722
D078 Determination of IgM class antibodies to Mycoplasma hominis (quant.) 15 1 057
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 705
D110 Mycoplasma pneumoniae IgA (quant) 40 2 819
D115 Mycoplasma pneumoniae IgG (qual) 40 2 819
D120 Mycoplasma pneumoniae IgM (qual) 40 2 819
D124 IgG Yersinia enterocolitica and psevdotuberculosis 30 2 114
D125 IgA Yersinia enterocolitica and psevdotuberculosis 30 2 114
D322 AB Shigella flexneri (total) 60 4 229
D323 AB Shigella sonnei (total) 60 4 229
S070 Ureaplasma urealiticum IgA 67 4 722
S075 Ureaplasma urealiticum IgG 67 4 722
S231 Anti-Salmonella A,B,C1, C2, D, E 22 1 550
S232 Anti-Salmonella Typhi Vi-antigen 22 1 550
S233 Anti-Corinebacterium Diphtheriae 22 1 550
C053 Helicobacter pylori IgM 44 3 101
C063 Helicobacter pylori IgA 44 3 101
C103 Immunoblot Borrelia burgdorferi IgG 60 4 229
C104 Immunoblot Borrelia burgdorferi IgM 60 4 229
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 705
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 705
S006 Antigen Legionella pneumophila in urine 30 2 114
S007 Determination of antigen Legionella pneumophila in urine (express test) 25 1 762
S008 Determination of streptococcus pneumoniae antigen 25 1 762
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 4 722
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 4 722
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 4 722
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 4 722
D311 Lamblia intestinalis IgG, IgM, IgA 47 3 312
D312 Lamblia intestinalis IgM 47 3 312
D315 Antibody to ascaris antigen IgG (qual.) 40 2 819
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 4 722
D325 Antibodies to Opistorchis IgG (quantitatives) 67 4 722
D326 Antibodies to Toxocara IgG (quantitative) 67 4 722
D327 Antibodies to Trichinella lgG (quantitative) 67 4 722
D328 Antibodies Ascaris IgG (quantitative) 67 4 722
D329 The blood test for trichinosis (rostirolla) 18 1 269
D330 The blood test for toxocariasis (rostirolla) 18 1 269
D331 Blood test for clonorchiasis (IgG) by ELISA 24 1 691
D332 The blood test for anisakis (IgG) by ELISA 24 1 691
D333 Determination of antibodies class G (IgG) to the causative agent of leishmaniasis (IgG) in the blood by ELISA 27 1 903
C049 Strongyloides stercoralis antibodies 44 3 101
C051 Taenia solium antibodies, IgG 44 3 101
C055 Fasciola hepatica antibodies, IgG 44 3 101
C057 Schistosoma mansoni antibodies, IgG 44 3 101
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 2 044
C024 Toxoplasma gondii IgM (qual) 38 2 678
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 3 101
S220 Toxoplasma IgG Avidity 46 3 242
C625 Entamoeba sp AB (total) 80 5 638
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 1 903
C205 Total T3 27 1 903
C210 Free T3 27 1 903
C215 Total T4 27 1 903
C220 Free T4 27 1 903
C222 Calcitonin 40 2 819
C223 Thyroglobulin 40 2 819
C224 Thyroid Binding Globulin (TBG) 40 2 819
Reproduction
B151 Dihydrotestosterone 53 3 735
C100 Follicle stimulating hormone 29 2 044
C105 Luteinising hormone 29 2 044
C106 Globulin, linking sex hormones (SHBG) 47 3 312
C110 Testosterone 29 2 044
C115 Prolactin 29 2 044
C117 Testosterone Free 47 3 312
C125 Estradiol 29 2 044
C126 Estriol Free 38 2 678
C130 Progesterone 29 2 044
C141 Inhibin В 93 6 554
C143 AMH (Anti-Mullerian Hormone) 93 6 554
C159 Definition of Macroprolactin 10 705
C227 Androstenedione 60 4 229
C400 Beta HCG 33 2 326
C404 Androstanediol glucuronide 50 3 524
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 80 5 638
IVF83 Evaluation of ovarian reserve 197.6 13 926
Follicle stimulating hormone
Fertility specialist consultation including ultrasound examination
AMH (Anti-Mullerian Hormone)
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 2 678
B531 17-alpha-Hydroxy-Progesteron 29 2 044
B536 Free cortisol (urine, 24h) 40 2 819
C120 Cortisol 29 2 044
C135 Dehydroepiandrosterone 33 2 326
C140 Adrenocorticotrophin 53 3 735
C178 Comprehensive blood test for unsaturated fatty acids of the Omega-3 family: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), gas chromatography - mass spectrometry (GC-MS) method 39 2 749
C179 Determination of the Omega-3 index (assessment of the risk of sudden cardiac death, myocardial infarction and other cardiovascular diseases), gas chromatography - mass spectrometry (GC-MS) method) 46 3 242
C180 A comprehensive blood test for unsaturated fatty acids of the Omega-6 family: linoleic, gamma-linolenic, digamogamma-linolenic, arachidonic, eicosadienic, docosadienic, docosatetraenoic acids, gas chromatography - mass spectrometry (GC-MS) method 39 2 749
C181 Comprehensive blood test for unsaturated fatty acids of the Omega-3 and Omega-6 family, gas chromatography - mass spectrometry (GC-MS) method 78 5 497
C452 Determination of cortisol in saliva 25 1 762
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 60 4 229
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 115 8 105
C462 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, estrogens, progestogen, their precursors and metabolites (16 indicators): 17-Oh-pregnenolone, testosterone, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, аndrostenedione, cortisol, cortisone, 11-deoxycortisol, 21-deoxycortisol, deoxycorticosterone, corticosterone, estradiol, estron, estriol, progesterone, 17-hydroxyprogesterone in the blood 114 8 034
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 8 950
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 8 950
G123 Mucoviscidosis CFTR 300 21 143
G423 A study of the fragmentation of sperm DNA by the method of SCD 265 18 676
G424 Study of DNA fragmentation in sperm by TUNEL (without gradient) 265 18 676
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 3 242
C132 Parathormone 47 3 312
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 3 101
C147 Bone resorption - deoxypiridinolin 67 4 722
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 5 638
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 3 242
B527 Somatomedin-C 46 3 242
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 2 819
B533 Proinsulin 60 4 229
B534 С-peptide 47 3 312
B539 Antibody-GAD 53 3 735
C108 Leptin 53 3 735
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 5 286
C158 Melatonin 48 3 383
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 3 735
BIOGENIC AMINES
C700 Serotonin 60 4 229
C800 Histamine 60 4 229
C900 Tryptase 75 5 286
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C157 Catecholamines and serotonin 36 2 537
C118 Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 60 4 229
C172 Determination of metabolites of biogenic amines: homovanilic acid (GVK), vanillin-mandelic acid (IUD) in urine, 24 h. 20 1 410
C173 Definition of free fractions of a metanefrin and normetanefrin (nekonyyugirovanny with SO4) in urine, 24 h. 23 1 621
C174 Determination of total epinephrine and norepinephrine metabolites: metanephrine, normetanephrine (free and conjugated with SO4) in urine, 24 h. 23 1 621
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 410
C311 Specific IgE for Allergen Mix / qual 33 2 326
C312 Single recombinant allergic components, inhalation (One name) 20 1 410
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 775
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 410
C315 General Inhalation Allergy Panel 160 11 276
C340 General Food Panel 160 11 276
C350 Allergy Panel/ primary screening 120 8 457
C351 Allergy pediatric panel, IgE (20 allergens) 156 10 994
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 1 973
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 1 550
C362 Antibacterial drugs (antibiotics) (specific IgE), one name. 10 705
C363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 10 705
C364 Local anesthetics (specific IgE). One name. 10 705
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 19 1 339
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 18 1 269
C367 Local anesthetics (specific IgG). One name. 18 1 269
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 1 903
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 1 550
C370 Allergochip ImmunoCAP ISAC (112 allergic components ) 425 29 952
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 846
C382 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel house dust, mixed hx2: h2 Hollister-Stier Labs, d1 dermatophagoides pteronyssinus, d2 dermatophagoides farinae, i6 crotonbug (blatella germanica) 13 916
C383 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel molds, mixed mx1: m1 Penicillium notatum (P. chrysogenum), m2 Cladosporium herbarum, m3 Aspergillus fumigatus, m6 Alternaria alternata 13 916
C384 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel molds, mixed mx2: m1 Penicillium notatum (P.chrysogenum), m2 Cladosporium herbarum, m3 Aspergillus fumigatus, m5 Candida albicans, m6 Alternaria tenuis, m8 Setomelanomma rostrata 13 916
C385 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pets (epithelium), mixed ex1: e1 cat (dander), e5 dog (dander), e3 horse (dander), e4 cow (dander) 15 1 057
C386 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pets, mixed ex2: e1 cat (dander), e5 dog (dander), e6 guinea pig (epithelium), e87 rat (epithelium, serum proteins and urine), е88 mouse (epithelium, serum proteins and urine) 19 1 339
C387 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel rodents, mixed ex70: e6 guinea pig (epithelium), e82 rabbit (epithelium), e84 hamster (epithelium), e87 rat (epithelium, serum and urine proteins), e88 mouse (epithelium, urine and serum proteins) 13 916
C388 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel bird feathers, mixed ex72: e78 budgerigar (feather), e201 canary (feather), e196 parakeet (feather), e213 parrot (feather), e214 wren (feather) 15 1 057
C389 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx5: t2 alder, t4 hazel, t8 elm, t12 white willow, t14 poplar 15 1 057
C391 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx6: t1 maple, t3 birch, t7 white oak, t5 Beech, t10 walnut 15 1 057
C392 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx9: t2 alder gray (alnus incana); t3 white birch (betula verrucosa); t4 common hazell (corylus avellana); t7 white oak, t12 white willow 13 916
C393 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pollen early-flowering meadow grasses, mixed gx1: g3 cocksfoot (dactylis glomerata), g4 meadow fescue (festuca elatior), g5 perennial ryegrass (chaff); g6 timothy grass (phleum pratense), g8 kentucky bluegrass 15 1 057
C394 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx1: w1 ragweed, w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w11 ash pan (saltwort) 15 1 057
C395 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx2: w2 ambrosia golometelchataya, w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w15 quinoa 15 1 057
C396 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx3: w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w12 goldenrod, w20 stinging nettle 19 1 339
C397 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel infant formula, mixed fx5: f1 egg white, f2 cow's milk, f3 cod, f4 wheat flour, f13 peanuts, f14 soybeans 15 1 057
C398 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel seafood, mixed fx2: f3 atlantic cod, f24 northern shrimp, f37 blue mussel, f40 tuna, f41 salmon 15 1 057
C399 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel fish mixed fx74: f3 atlantic cod, f205 herring, f206 mackerel, f254 flounder 15 1 057
C470 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel meat mixed fx74: f26 pork, f27 beef, f83 chicken 19 1 339
C471 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel flour and cereal sesame, mixed fx3: f4 wheat, f7 oat, f8 maize, f10 sesame seed, f11 buckwheat 15 1 057
C472 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel lour, cereal, mixed FX20: f4 wheat, f5 rye, f6 barley, f9 rice 15 1 057
C473 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel vegetables and legumes, mixed fx13: f12 pea, f15 white beans, f31 carrot, f35 potato 15 1 057
C474 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel vegetables, mixed fx14: f25 tomato, f214 spinach; f216 white cabbage, f218 paprika and sweet pepper 15 1 057
C475 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel nuts, mixed fx1: f13 peanut, f17 hazel nut, f18 brazil nut, f20 almond, f36 coconut 15 1 057
C476 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel citrus and fruit, mixed fx15: f33 orange, f49 apple, f92 banana, f95 peach 15 1 057
C477 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel fruits and melons, mixed fx21: f84 kiwi fruit, f87 melon, f92 banana, f95 peach, f210 peneaple 15 1 057
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 22 552
C463 Determination of class-specific immunoglobulin (IgG) for evaluation of nutritional maladjustment within the program "Immunohealth IT" 300 21 143
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 2 467
P019 DNA Salmonella species in stool 25 1 762
P021 Colibacillosis 40 2 819
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 2 749
P009 Mycoplasma pneumoniae DNA 22 1 550
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 4 722
P030 HSV I & II 20 1 410
P031 Human Papilloma virus 31, 33 20 1 410
P032 Human Papilloma virus 6,11 20 1 410
P033 Herpes Simplex virus II 20 1 410
P035 H. Papilloma virus 16, 18 20 1 410
P042 Varicella-Zoster virus 20 1 410
P070 Cytomegalovirus 20 1 410
P080 Epstein-Barr virus 20 1 410
P105 Human Papilloma virus sp. 20 1 410
P004 Rubella Virus in blood (qual) 40 2 819
P120 Herpes Simplex virus VI (qual) 18 1 269
P125 Enterovirus (RNA) 33 2 326
P126 DNA Pneumocystis carinni 17 1 198
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of coronaviruses, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 3 524
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 70 4 933
P129 RNA Zika virus (blood) 80 5 638
P130 RNA Zika virus (ejaculate) 33 2 326
P131 RNA Zika virus (Amniotic fluid) 33 2 326
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 4 933
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 30 2 114
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 057
P136 Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 54 3 806
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 410
P036 M.Tuberculosis-M.bovis 22 1 550
P038 Streptococcus group A (pyogenes) 22 1 550
P065 Listeria monocytogenes 22 1 550
P075 Pseudomonas aeruginosa 22 1 550
P085 Bordetella pertussis (PCR) 22 1 550
P095 Helicobacter pylori 38 2 678
P097 Haemophilus influenzae 20 1 410
P098 Streptococcus pneumoniae 20 1 410
P099 DNA Treponema pallidum 20 1 410
P103 Legionella pneumophila 10 705
P138 Study of feces on Yersinia pseudotuberculosis by PCR 10 705
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 410
P005 Mycoplasma hominis 20 1 410
P006 Mycoplasma genitalium 20 1 410
P015 Ureaplasma species 20 1 410
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 410
P020 Neisseria gonorrhoeae 20 1 410
P025 Gardnerella vaginalis 20 1 410
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 410
P012 Toxoplasma gondii 22 1 550
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 1 550
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 3 735
P045 Hepatitis B qualitive (HBV-DNA) 33 2 326
P050 Hepatitis C quant. (HCV-RNA) 253 17 830
P055 Hepatitis C qualitive (HCV-RNA) 38 2 678
P060 HCV-RNA (genotype determination) 40 2 819
P061 Hepatite G qual. (HGV-RNA) 40 2 819
P062 Hepatite D qual. (HDV-RNA) 40 2 819
P008 Hepatitis A Virus RNA (HAV-RNA) 40 2 819
P063 Genotype of hepatitis B 35 2 467
P101 Hepatitis C Virus RNA (ultrasensitive method) 75 5 286
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 186 13 109
P132 Definition of HIV RNA (type 1) (quantitative) 76 5 356
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 10 994
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 150 10 571
G122 SNP identification in human IL28B gene 60 4 229
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 16 209
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 14 800
G136 FISH panel Myelodysplastic syndrome (6 probes) 245 17 267
G137 CYP2D6 analysis polymorphisms 140 9 867
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 30 305
G139 Familial adenomatous polyposis , polypoid colon cancer 430 30 305
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 574 40 453
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 57 790
G156 BRCA1 и BRCA2 polymorphism 225 15 857
G157 Non Invasive Prenatal Test (NIPT) Natera (USA) Basic panel. Down, Edwards, Patau syndromes 1000 70 476
G159 Sequence SCN1 A (Dravet syndrome) 825 58 143
G160 Fragile X mental retardation syndrome (methylation) 188 13 249
G161 Fragile X mental retardation syndrome, premutation (PCR) 263 18 535
G162 Clinical sequencing ekzom, the family (4000 genes) 1700 119 809
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 135 9 514
G164 Analysis of polymorphisms associated with the metabolism of lactose (2 points) 40 2 819
G165 Paternity test 480 33 828
G167 Non Invasive Fetal Rhesus factor Determination 188 13 249
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 10 571
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 800 56 381
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 800 56 381
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G195 Non Invasive Prenatal Test (NIPT) Natera (USA) + microdeletion 1040 73 295
G196 Non Invasive Prenatal Test (NIPT) for twin pregnancy, donor programs and surrogate mothers 700 49 333
G197 Calreticulin (CALR) 77 5 427
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 587 41 369
G216 Genetic predisposition to breast cancer and ovarian cancer 120 8 457
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 230 16 209
G232 Stomach cancer 454 31 996
G233 Pancreas cancer 98 6 907
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 590 41 581
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 200 14 095
G254 Sensorineural hearing loss 40 2 819
G255 Muscle atrophy 71 5 004
G256 Long QT syndrome 95 6 695
G264 Lactose intolerance 67 4 722
G265 Gilbert's syndrome - a confirmatory test 40 2 819
G268 Psoriasis 71 5 004
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 43 3 030
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 40 2 819
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 11 699
G281 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 195 13 743
G282 Activity of genes VEGF, VEGF in cancer of the thyroid gland (blood tests) 220 15 505
G289 Activity GATA2 gene for prostate cancer (blood test) 195 13 743
G290 Activity IGF1 gene for prostate cancer (blood test) 195 13 743
G291 Activity IGF2 gene for prostate cancer (blood test) 195 13 743
G292 Activity IL4 gene for prostate cancer (blood test) 195 13 743
G293 Activity IL10 gene for prostate cancer (blood test) 195 13 743
G294 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (blood test) 311 21 918
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 117 8 246
G300 Preimplantation aCGH diagnosis of chromosomal abnormalities (fresh cycle) for each specimen 600 42 286
G303 Preimplantation CGH diagnosis of chromosomal abnormalities cryo cycle (translocation) for each specimen 1000 70 476
G304 Preimplantation NGS diagnosis of chromosomal abnormalities (cryo cycle) for each specimen 510 35 943
G305 PGD ​​monogenic diseases 1 cat of complexity: development of individual test systems (Rh, cystic fibrosis , spinal amyotrophy, fam Mediterranean fever, Duchenne muscular dystrophy, Becker and other dis, which is partially developed test system, dev of HLA- typing) 1550 109 238
G306 PGD ​​monogenic diseases 2 category of complexity: development of individual test systems (diseases for which there are no ready-made elements of the test system) 2660 187 466
G307 PGD ​​monogenic diseases 3 category of complexity: development of individual test systems (PGD for simultaneous diagnosis of two diseases, or more genes of disease) 4430 312 208
G308 PGD ​​monogenic diseases 1 category of complexity 1330 93 733
G309 PGD ​​monogenic diseases 2 category of complexity 2215 156 104
G310 PGD ​​monogenic diseases 2 category of complexity 3325 234 332
G313 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 435 30 657
G314 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 535 37 705
G315 Full sequencing of exome 2105 148 352
G316 Panel "Diseases of conjunctive tissue" 640 45 105
G317 Panel "Patrimony of cardiopathy" 635 44 752
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 645 45 457
G319 Search for mutations in the gene CAV 3 135 9 514
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 605 42 638
G321 Panel "Hypertension" 80 5 638
G322 Panel "Hypertension and selection of pharmaceutical drugs" 140 9 867
G323 Velocardiofacial syndrome: searching for mutations in TBX1 gene 360 25 371
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 180 12 686
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 555 39 114
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 245 17 267
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 170 11 981
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 170 11 981
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 800 56 381
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 580 40 876
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 245 17 267
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 230 16 209
G333 Myriad MyRisk 3585 252 656
G334 Myriad BRCA1 Analysis 2145 151 171
G335 Myriad BRCA2 Analysis 2225 156 809
G336 Myriad COLARIS PLUS 2935 206 847
G337 Myriad MLH1 Analysis 1830 128 971
G338 Myriad MSH2 Analysis 1595 112 409
G339 Myriad MSH6 Analysis 1950 137 428
G340 Myriad PMS2 Analysis 1830 128 971
G341 Myriad MYH Sequence Analysis 1751 123 403
G342 Myriad Comprehensive MELARIS 1667 117 483
G343 Myriad Comprehensive PANEXIA 2935 206 847
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 75 5 286
G348 Genetic testing for gross SPAST- and ATL1-gene deletion and duplication associated with Hereditary spastic paraplegia (HSP) 150 10 571
G352 Study of gene mutation revealed among family members with Hereditary spastic paraplegia (HSP) 65 4 581
G353 Prenatal DNA-diagnostics for Hereditary spastic paraplegia (HSP) 180 12 686
G355 Myriad BRAC Analysis 2540 179 009
G356 Myriad Single-Site BRACAnalysis 1184 83 443
G357 Myriad MultiSite 3 BRACAnalysis 1387 97 750
G358 Myriad Reflex BRACAnalysis 2305 162 447
G359 Myriad BRACAnalysis Rearrangement Test (BART) 1476 104 022
G360 Myriad Single-Site COLARIS 1184 83 443
G361 Myriad COLARIS AP PLUS 2540 179 009
G362 Myriad Single-Site COLARIS AP 1184 83 443
G363 Myriad MYH Mutation Panel 1100 77 523
G364 Myriad Reflex MYH Sequence Analysis 1500 105 714
G365 Myriad Single-Site MELARIS 1184 83 443
G366 Myriad Single-Site PANEXIA 1184 83 443
G367 Myriad PALB2 Analysis 1880 132 495
G375 NIPT. Natera (USA)+microdeletions (Full study. Hromosomal wide syndromes and mutations) 1040 73 295
G376 Molecular karyotyping abortion material OPTIMA 310 21 848
G377 Chromosomal micrometrical analysis of abortive material Standard 530 37 352
G378 Non-invasive prenatal DNA Harmony test (Ariosa) 600 42 286
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 454 31 996
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 460 32 419
G388 The allocation and storage of DNA 23 1 621
G389 Panel "Disorders of hemostasis" 30 tokens 210 14 800
G391 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy at 21 chromosome (Down syndrome) + sex determination 308 21 707
G392 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy 21,13 and 18 on the chromosome (Down syndrome, Patau, Edwards) + definition of sex (for pregnancy two fruits) 532 37 493
G393 Non-invasive prenatal test PtenaTest to determine the presence of fetal Trisomy 21,13 and 18 on the chromosome (Down syndrome, Patau, Edwards) + numerical disorders of sex chromosomes and sex determination 532 37 493
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 147 10 360
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 133 9 373
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 244 17 196
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 355 25 019
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 355 25 019
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 277 19 522
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 366 25 794
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 310 21 848
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 222 15 646
G425 The study of the intestinal microbiota by the method of NGS sequencing of specific 16s RNA 220 15 505
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 14 095
TISSUE TYPING
G020 HLA TYPING B27 200 14 095
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 5 638
M003 Bacterioscopic stained smear 30 2 114
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 3 312
M006 Determination of microbiocenosis by chromatography-mass spectrometry (MSMM) 111 7 823
M010 Mycology & Fungigram 90 6 343
M100 Disbacteriosis 107 7 541
M130 Corynebacterium diphtheriae (BL) 29 2 044
M135 Enteropathogenic bacteria (BD) 35 2 467
M170 Staphylococcus aureus 52 3 665
M350 Yersinia enterocolitica (stool culture) 52 3 665
M560 Listeria (with resistance) 38 2 678
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 53 3 735
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 53 3 735
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 18 1 269
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 410
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 18 1 269
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 16 1 128
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 15 1 057
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 10 571
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 7 048
M151 Microbiology of blood by fungi (double reseeding) 130 9 162
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 5 638
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 9 162
M156 Mycology of sputum by fungi, microscopy and culture 80 5 638
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 9 162
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 7 752
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 457
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 5 638
M136 Mycology of conjunctiva discharge by fungi (culture) 100 7 048
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 8 457
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 4 933
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 5 638
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 6 343
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 8 105
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 5 638
COMPLEX LABORATORY TESTS
K001 Cardiorisk 440 31 009
Prothrombin+INR
Homocysteine
Cholesterol
Cholesterol-HDL
Cholesterol-LDL
Triglycerides
Sodium/Potassium/Chloride
Lactatedehydrogenase (LDH)
Creatine Kinase
Creatine Kinase MB
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
C-Reactive Protein
Myoglobin
Troponin I
BNP (brain natriuretic peptide)
K002 Lipidic screening 200 14 095
Homocysteine
Cholesterol
Cholesterol-HDL
Cholesterol-LDL
Triglycerides
Lipoprotein A
APO-A-1 protein
APO-B protein
K003 Liver Function 120 8 457
Albumin
Total protein
Bilirubin total
Bilirubin direct
Lactatedehydrogenase (LDH)
Creatine Kinase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K004 TORCH 379 26 710
Anti-CMV IgG
Anti-CMV IgM
Anti-Rubella IgG
Anti Rubella IgM
Anti-HSV 1 IgG
Anti-HSV 1 IgM
Anti-HSV 2 IgG
Anti-HSV 2 IgM
Toxoplasma gondii IgG (quant)
Toxoplasma gondii IgM (qual)
K005 Thyroid gland 240 16 914
Thyroglobulin antibody
Thyroperoxidase antibody
Thyroid stimulating hormone
Total T3
Free T3
Total T4
Free T4
Thyroglobulin
K006 Anemia 219 15 434
Cell Blood Count+differential
Sedimentation rate
Reticulocytes
Folic acid
Vitamin B12
Iron
Iron binding capacity
Transferrin
Ferritin
K007 Osteoporosis 201 14 166
Calcium (total)
Phosphate inorganic
Alk. Phosphatase
Osteocalcin
Parathormone
Bone resorption - deoxypiridinolin
K008 Biochemical screening 160 11 276
Cell Blood Count+differential
Sedimentation rate
Creatinine
Total protein
Urea
Glucose
Cholesterol
Bilirubin total
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K010.1 Complex "Chemotherapy. Biochemical screening" №1 90 6 343
Cell Blood Count+differential
Standard urine test
Albumin
Creatinine
Total protein
Urea
Uric acid
Glucose
Bilirubin total
Calcium (total)
Sodium/Potassium/Chloride
Amylase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K010.2 Complex "Chemotherapy. Biochemical screening" №2 85 5 990
Cell Blood Count+differential
Albumin
Creatinine
Total protein
Urea
Uric acid
Glucose
Bilirubin total
Calcium (total)
Sodium/Potassium/Chloride
Amylase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K011 Fibro Test/ Acti Test 300 21 143
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 26 781
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
K013 LifeSpan Lab Pre-Check Male 219 15 434
Vitamin D
Magnesium
Testosterone
Dehydroepiandrosterone
Insulin
K014 LifeSpan Lab Pre-Check Female 219 15 434
Vitamin D
Magnesium
Testosterone
Estradiol
Progesterone
Insulin
QUANTITATIVE ANALYSIS OF CYTOKINE MRNA EXPRESSION USING RT-PCR
G006 MMP-2 - study of lung cancer invasiveness 89 6 272
G100 TIMP-2 - study of lung cancer invasiveness 89 6 272
G008 TGF B - study of prostate cancer invasiveness 89 6 272
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 3 524
G010 BRCA1 4153delA 50 3 524
G011 BRCA1 185delAG 50 3 524
G012 BRCA1 C61>G 50 3 524
G014 BRCA1 2080delAA 50 3 524
G015 BRCA2 6174delT 50 3 524
G016 BRCA2 9318 delAAAA 50 3 524
G021 CHEK2 ivs2+1G>A 50 3 524
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 85 5 990
G053 BCR-ABL p190 t(9;22) 85 5 990
G054 BCR-ABL p230 t(9;22) 85 5 990
MUTATIONS, CHIMERISM
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 150 10 571
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 6 272
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 60 4 229
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 56 3 947
G107 Deletion in 12 exon gene Jak-2 kinase 80 5 638
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 105 7 400
G152 Germinal mutation 60 4 229
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 105 7 400
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 731 51 518
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 90 6 343
G374 Prenatal DNA diagnosis (Wilson's Disease) 180 12 686
G381 PMP22(1.5-MB Del) 29 2 044
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 29 2 044
G383 PMP22 (1-BP INS, 325G; rs80338763) 29 2 044
G384 PMP22 (Ala67Thr: rs104894623) 29 2 044
G385 PMP22 (EX2-3DEL; nsv1197510) 29 2 044
G386 PDGFRα, FIP1L1 - markers of eosinophilia 85 5 990
G387 Genotyping on the RH factor, including heterozygous carrier 126 8 880
G390 Panel "Phacomatosis and hereditary cancer" 631 44 470
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 127 8 950
G408 Analysis of carriers of spinal ametropia 144 10 149
G409 Screening for hereditary diseases (2500 genes) 632 44 541
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 60 4 229
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 209 14 729
G412 Search 9 most frequent mutations in the CYP210HB gene 144 10 149
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 171 12 051
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 78 5 497
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1108 78 087
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1218 85 840
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1528 107 687
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1639 115 510
G420 Confirmation of previously found mutation sequencing by Sanger 115 8 105
G429 Parkinson disease - mutation screening of exons 8 to 11 of the GBA gene 115 8 105
G430 Wilson-Konovalov disease - screening of the coding region of the atp7b gene 665 46 866
G431 BAS and frontotemporal dementia - expansion in c9orf72 gene 90 6 343
G432 Neurodegenerative diseases - APOE gene genotyping 56 3 947
G433 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy (CADASIL): analysis of the most frequent mutations in the NOTCH3 gene 115 8 105
G434 Frontal-temporal dementia - mutational screening of the coding region of the GRN gene 270 19 028
G435 BAS - screening of the coding region of the SOD1 gene 270 19 028
G442 The blood test for the syndrome Gerstmann-Straussler-Sheinker: search for mutations in the gene PRNP 170 11 981
G443 Complex genetic research: hereditary diseases of the gastrointestinal tract 635 44 752
G444 Search for mutations in 63 genes responsible for SPG in spastic paraplegia of Strumpel 645 45 457
G445 Full genome sequencing GenomeUNI 1840 129 676
G446 Research on the genome FERTY 1440 101 485
G447 Search for mutations in the FKTN gene (Muscular dystrophy of the Fukuyama type) 400 28 190
G448 Finding a relative’s identified mutations in this family (Muscular dystrophy of the Fukuyama type) 90 6 343
G449 Search for frequent mutations in CAPN3, FKRP, ANO5, SGCA genes (muscular dystrophy of the lumbar) 105 7 400
G450 Search for mutations in genes CAPN3, DMD, EMD, SGCG, SGCA, SGCB,SGCD, TCAP, FKRP, POMT1, ANO5, FKTN, ISPD, LMNA, CAV3 (muscular dystrophy of the lumbar) 645 45 457
G451 Search for mutations in the FKRP gene (muscular dystrophy of the lumbar) 130 9 162
G452 Search for mutations in the SGCA gene (muscular dystrophy of the lumbar) 200 14 095
G453 Search for mutations in the SGCB gene (muscular dystrophy of the lumbar) 200 14 095
G454 Search revealed in this family mutations in a relative (muscular dystrophy of the lumbar) 90 6 343
G455 Prenatal DNA diagnosis (muscular dystrophy of the lumbar) 180 12 686
G456 Finding mutations in the EMD gene (Emery-Dreyfus muscular dystrophy) 130 9 162
G457 Finding mutations in the LMNA (Emery-Dreyfus muscular dystrophy) 335 23 609
G458 Finding mutations in the FHL1 gene (Emery-Dreyfus muscular dystrophy) 270 19 028
G459 Search revealed in this family mutation in a relative (Emery-Dreyfus muscular dystrophy) 65 4 581
G460 Prenatal DNA diagnosis Emery-Dreyfus muscular dystrophy 180 12 686
G461 Search for deletions and duplications in the DMD gene in boys (Duchenne/Becker muscular dystrophy) 200 14 095
G462 Search deletions and duplications in the patient's relatives in the female line (Duchenne/Becker muscular dystrophy) 235 16 562
G463 Search for point mutations in the DMD gene (Duchenne/Becker muscular dystrophy) 645 45 457
G464 Search for a point mutation identified in this family from a relative (Duchenne/Becker muscular dystrophy) 65 4 581
G465 Prenatal DNA diagnosis (Duchenne/Becker muscular dystrophy) 180 12 686
G466 Determination of mutations in MYD88 GENE (L265P) (associated with primary resistance to ibrutinib) 130 9 162
G467 Determination of B-cell clonal rearrangement of heavy chain IG (IgH) genes 138 9 726
G468 Chromosomal micromatrix analysis advanced 664 46 796
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
EXPRESS DIAGNOSTICS
E002 General Biochemistry express screening 122 8 598
C-Reactive Protein
Albumin
Bilirubin total
Alanine Amino Transferase
Asparate Amino Transferase
Gamma Glutamyle Transferase
Alk. Phosphatase
Amylase
Glucose
Urea
Creatinine
Calcium
Uric acid
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 15 011
M206 Histological examination of the placenta 300 21 143
H250 Histology of tumor surgical samples 389 27 415
H299 Intraoperative (urgent) histology and cytology 200 14 095
H270 Histology of breast wide local excision (lumpectomy) specimen 389 27 415
H271 Histology of mastectomy speciment 367 25 865
H272 Histology of sentinel lymph node with IHC if necessary 280 19 733
H273 Histology of lymph node dissection speciment 213 15 011
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 8 950
M202 Hystology with supplementary staining for helicobacter pylori 227 15 998
M203 Multiple histology 3 samples and more 344 24 244
H205 Histology of scrapings of the uterus 213 15 011
H206 Histology of the mammary gland punctates 213 15 011
H207 Histology of liver bioptates 213 15 011
H208 Histology of CT-guideline needle biopsy 397 27 979
H209 Histology of skin (PUNCH-biopsy) 213 15 011
H210 Histology of skin tumors 198 13 954
H211 Histology of bone marrow patho bioptate 280 19 733
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 10 994
H231 Consultation with the making of histology specimens with paraffin blocks 224 15 787
H232 Consultation with the making of specimens and immunohistochemistry 358 25 230
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe, Israel (telepathology) 389 27 415
H234 Consultation histological slides by a qualified pathologist USA, University of Southern California 445 31 362
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 6 484
H274 Consultation of histology and cytology slides by the head of pathology lab 215 15 152
H275 Consultation of histology specimens of specialist-pathologist from Europe, Helios Clinic (telepathology) 498 35 097
CYTOLOGY
M300 Citology / 1 lame 75 5 286
M301 Cytologic cervical smear (Pap Smear) 94 6 625
M302 Integrated cytology PAP-test and HPV typing 117 8 246
M303 Complex immunocytochemical study of thyroid neoplasms 450 31 714
M304 Complex cytological and immunocytochemical examination of pleural fluid 110 7 752
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 5 497
Z303 Cytology of the mammary gland 75 5 286
Z304 Cytology of the thyroid gland punctate 117 8 246
Z305 Cytology of liquid 78 5 497
Z306 Cytology of endoscopic material 56 3 947
Z307 Cytology of scrapings from the surface of the skin and mucous 78 5 497
Z308 Cytology of surgical samples 78 5 497
Z309 Cytology of the lymph nodes punctate 94 6 625
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 5 497
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 22 1 550
Z315 Urgent cytology performed during endoscopic procedures (preparation and evaluation of cytologic drug clinical laboratory diagnostic by cytologist) 150 10 571
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 19 592
I002 Immunohistochemical differential diagnosis of tumors 389 27 415
I003 Immunohistochemistry of one marker panel differential diagnosis 213 15 011
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 32 207
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 256 18 042
I006 Immunocytochemistry 256 18 042
I007 Immunohistochemistry with assessment of the mutational status of the ALK gene 220 15 505
I008 Complex histological and immunohistochemical analysis of biopsies of the bladder 256 18 042
I009 Immunohistochemical study of PDL-1 gene expression 275 19 381
I010 Immunohistochemical study of up to 5 antibodies 229 16 139
I011 Immunohistochemical study from 5 to 10 antibodies 361 25 442
I012 Immunohistochemical study from 10 to 20 antibodies 541 38 127
I013 Complex histological and immunohistochemical study of biopsies of the prostate 450 31 714
GENETIC ANALYSIS
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 28 190
I501 Cytogenetic study by hybridization in situ FISH/CISH (one tube) in sections from paraffin blocks 305 21 495
I506 Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 308 21 707
I507 Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 313 22 059
I508 Determination of the mutational status of the RET gene by in situ hybridization in a tumor tissue sample 313 22 059
I509 Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 313 22 059
I510 Cytogenetic study (analysis of stable chromosomal aberrations) by in-situ hybridization in a tumor tissue sample 301 21 213
I511 Determination of the mutational status of the NMYC gene by in situ hybridization in a tumor tissue sample 315 22 200
I512 Determination of the mutational status of the CMYC gene by in situ hybridization in a tumor tissue sample 315 22 200
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 20 227
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 20 227
G202 EGFR gene amplification (sensitivity to cetuximab) 259 18 253
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 12 545
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 16 632
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 7 893
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 328 23 116
G207 Determination of the methylation status of the promoter body and MGMT gene 177 12 474
G368 Tissue test in ovarian cancer treatment 3213 226 439
G369 Agression degree in prostate cancer 4310 303 751
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 4310 303 751
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 171 679
G404 Express research of additional biomarkers 226 15 928
G405 Biological profiling of tumor (Caris Target Now) only NGS 3855 271 685
G406 Biological profiling of tumor (Caris Target Now) full profile 6000 422 855
G419 Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1108 78 087
G426 Molecular genetic testing of mutations in IDH1 gene in a sample of tumor tissue 190 13 390
G427 Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 190 13 390
G436 Molecular genetic study of mutations in the PIK3CA gene in a tumor tissue sample 145 10 219
G437 Molecular genetic research in the NRAS gene in biopsy/surgical tissue sample 150 10 571
G438 Immunohistochemical study of PDL-1 gene expression 165 11 629
G439 Solo genetics standard: tumour tissue analysis (17 biomarkers) by the NGS method 737 51 941
G440 Solo Genetics Advanced: tumour tissue analysis (50 biomarkers) by NGS method 1550 109 238
G441 Comprehensive genetic study of thyroid tumors by NGS 1550 109 238
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 305 21 495
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 17 548
I504 Translocation in synovial sarcoma SYT/SSX 305 21 495
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 305 21 495

    Mobile application EMC